2m 2m 2m 2m 2m 2m 2m
BIOMX (PHGE)
NYSE
$0.83-$0.05 (-5.76%)
Price as of Jun 03, 2026 7:56 PM EDT- $12.8MMarket Cap
- -90.80%1-Year Change
- BiotechnologyIndustry
BIOMX (PHGE)
$0.83-$0.05 (-5.76%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | 518,000 N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 +100.00% | -518,000 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | 616,000 +106.02% | 299,000 +166.96% | 112,000 -30.00% | 160,000 -98.58% | |
Research and Development Expense | -21.3M -13.67% | -24.7M +47.70% | -16.7M +2.79% | -16.2M -28.36% | |
Depreciation and Amortization Expense | 2.9M +62.06% | 1.8M +107.00% | 871,000 -65.44% | 2.5M -1.75% | |
Total Operating Expenses | 9.6M -18.24% | 11.8M +36.14% | 8.7M -8.52% | 9.5M -16.07% | |
Operating Profit | -41.5M -6.87% | -44.5M +75.65% | -25.3M -6.87% | -27.2M -23.24% | |
Interest Income | 460,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -850,000 -18.89% | -1.0M -56.41% | -2.4M +16.19% | -2.1M +195.99% | |
Interest Income and Expense and Net | -390,000 -62.79% | -1.0M -56.41% | -2.4M +16.19% | -2.1M +195.99% | |
Total Nonoperating Income and Expense | -724,000 -21.22% | -919,000 -173.58% | 1.2M +38.47% | 902,000 +45,000.00% | |
Income before Taxes | -36.2M +104.31% | -17.7M -32.25% | -26.1M -7.45% | -28.3M -20.33% | |
Income Taxes | 7,000 -46.15% | 13,000 -43.48% | 23,000 -64.62% | 65,000 -2.99% | |
Extraordinary Items | 11.8M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -36.2M +104.20% | -17.7M -32.26% | -26.2M -7.59% | -28.3M -21.83% | |
Net Income from Continuing Operations Applicable to Common | -36.2M +104.31% | -17.7M -32.25% | -26.1M -7.45% | -28.3M -22.01% | |
Basic EPS and Net Income | 22.19 +1,409.52% | 1.47 +188.24% | 0.51 -46.32% | 0.95 -31.65% | |
Diluted EPS and Net Income | 22.19 +560.42% | 3.36 +558.82% | 0.51 -46.32% | 0.95 -31.65% | |
Basic Weighted Average Shares | 1.6M -86.43% | 12.0M -76.58% | 51.3M +71.94% | 29.9M +14.79% | |
Diluted Weighted Average Shares | 1.6M -87.59% | 13.1M -74.40% | 51.3M +71.94% | 29.9M +14.79% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.4M -74.13% | 16.9M +13.07% | 14.9M -52.42% | 31.3M -49.55% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 2.0M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4.4M -74.13% | 16.9M +13.07% | 14.9M -55.28% | 33.3M -46.32% | |
Total Current Assets | 5.6M -72.83% | 20.5M +16.38% | 17.6M -52.19% | 36.9M -44.65% | |
Accumulated Depreciation | 5.4M -1.22% | 5.5M +57.97% | 3.5M +28.45% | 2.7M +159.08% | |
Property and Plant and Equipment and Net | 5.0M -0.34% | 5.0M +29.29% | 3.9M -18.54% | 4.8M -15.88% | |
Total Long-Term Assets | 208,000 -99.08% | 22.7M +207.06% | 7.4M -14.49% | 8.7M -23.80% | |
Total Assets | 5.8M -86.62% | 43.2M +72.73% | 25.0M -45.03% | 45.5M -41.62% | |
Income Taxes Payable | N/A N/A | 3.8M +192.55% | 1.3M +45.32% | 887,000 -60.96% | |
Total Short-Term Debt | N/A N/A | N/A N/A | 5.8M +16.42% | 5.0M +506.72% | |
Total Current Liabilities | 6.4M -22.84% | 8.3M -26.03% | 11.2M +40.77% | 7.9M -28.11% | |
Total Long-Term Debt | 15.0M 0.00% | 15.0M +177.67% | 5.4M -63.68% | 14.9M +3.21% | |
Total Long-Term Liabilities | 706,000 -93.47% | 10.8M +0.43% | 10.8M -34.92% | 16.6M -14.73% | |
Total Liabilities | 6.4M -61.85% | 16.7M +16.00% | 14.4M +22.82% | 11.7M -25.86% | |
Retained Earnings | -216.9M +20.03% | -180.7M +10.88% | -163.0M +19.13% | -136.8M +26.10% | |
Total Stockholders Equity | -1.3M -105.39% | 24.1M +683.77% | 3.1M -85.36% | 21.0M -55.74% | |
Total Shares Outstanding | 1.6M -91.23% | 18.2M -60.47% | 46.0M +53.39% | 30.0M +0.77% | |
Cash Flow | |||||
Cash from Operating Activities | -26.4M -28.64% | -37.0M +73.72% | -21.3M -26.83% | -29.1M +5.51% | |
Capital Expenditures | 2,000 -93.33% | 30,000 -40.00% | 50,000 -55.36% | 112,000 -96.96% | |
Cash from Investing Activities | 108,000 -84.90% | 715,000 -63.35% | 2.0M +192.60% | -2.1M -113.03% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 13.2M -65.63% | 38.4M +1,223.70% | 2.9M +892.81% | 292,000 -99.22% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -147.70% +184.38% | -51.94% -29.98% | -74.18% +61.78% | -45.85% -6.12% | |
Return on Equity | -316.90% +143.38% | -130.21% -39.99% | -216.99% +162.74% | -82.59% +19.69% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 0.87 -64.79% | 2.48 +57.33% | 1.58 -66.04% | 4.65 -23.02% | |
Cash Ratio | 0.68 -66.48% | 2.04 +52.87% | 1.33 -66.20% | 3.95 -29.82% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 3.63 +285.01% | 0.94 +194.35% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.45 +2.57% | 0.44 +123.14% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow